Patients with Spondyloarthritis and obesity who fail TNF antagonist therapy: Change the subcutaneous injection site before the biologic? Comment on: “Impact of obesity on the efficacy of different biologic agents in inflammatory diseases: A systematic review and meta-analysis” by Shan et al. Joint Bone Spine, 2019, 86, 173-183

Patients with Spondyloarthritis and obesity who fail TNF antagonist therapy: Change the subcutaneous injection site before the biologic? Comment on: “Impact of obesity on the efficacy of different biologic agents in inflammatory diseases: A systematic review and meta-analysis” by Shan et al. Joint Bone Spine, 2019, 86, 173-183

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Joint, bone, spine : revue du rhumatisme bone, spine : revue du rhumatisme, 2020-01, Vol.87 (1), p.103-104
Hauptverfasser: Brocq, Olivier, Acquacalda, Emilie, Florent, Amélie, Lascar, Tristan
Format: Artikel
Sprache:eng
Schlagworte:
Obesity
Spondyloarthritis
TNF antagonist
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:
ISSN:1297-319X
1778-7254
DOI:10.1016/j.jbspin.2019.09.003